QT
ABCL icon

Quantbot Technologies’s AbCellera Biologics ABCL Stock Holding History

Quantbot Technologies’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$121K Buy
+34,536
New +$124K ﹤0.01% 1287
2025
Q1 		– Sell
-5,739
Closed -$16.8K – 1420
2024
Q4 		$16.8K Buy
+5,739
New +$16K ﹤0.01% 1364
2023
Q3 		– Sell
-66,799
Closed -$432K – 1489
2023
Q2 		$432K Sell
66,799
-19,830
-23% -$135K 0.03% 723
2023
Q1 		$653K Buy
86,629
+69,417
+403% +$630K 0.05% 533
2022
Q4 		$174K Sell
17,212
-69,248
-80% -$800K 0.01% 956
2022
Q3 		$855K Buy
86,460
+21,351
+33% +$234K 0.06% 432
2022
Q2 		$693K Buy
+65,109
New +$551K 0.06% 468
2021
Q2 		– Sell
-435
Closed -$14K – 1412
2021
Q1 		$14K Buy
+435
New +$17.3K ﹤0.01% 1212

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return